Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.
Authors
Stiegeler, Emanuel
Glögl, Matthias
Lemmin, Thomas
Hansen, Simon
Wu, Yufan
Maliqi, Liridona
Foulkes, Caio
Morin, Mylène
Eroglu, Mustafa
Liechti, Thomas
Ivan, Branislav
Reinberg, Thomas
Schaefer, Jonas V
Karakus, Umut
Mann, Axel
Rusert, Peter
Publication Date
2021-11-18Journal Title
Nat Commun
ISSN
2041-1723
Publisher
Springer Science and Business Media LLC
Volume
12
Issue
1
Language
en
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Friedrich, N., Stiegeler, E., Glögl, M., Lemmin, T., Hansen, S., Kadelka, C., Wu, Y., et al. (2021). Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralization.. Nat Commun, 12 (1) https://doi.org/10.1038/s41467-021-27075-0
Description
Funder: Swiss government (through SERI) under grant agreement No.15.0337. Gilead HIV-1 Cure Grant 408 Clinical Priority Research Program of the University of Zurich Yvonne-Jacob Foundation Swiss HIV Cohort Study (SHCS) research foundation
Abstract
The V3 loop of the HIV-1 envelope (Env) protein elicits a vigorous, but largely non-neutralizing antibody response directed to the V3-crown, whereas rare broadly neutralizing antibodies (bnAbs) target the V3-base. Challenging this view, we present V3-crown directed broadly neutralizing Designed Ankyrin Repeat Proteins (bnDs) matching the breadth of V3-base bnAbs. While most bnAbs target prefusion Env, V3-crown bnDs bind open Env conformations triggered by CD4 engagement. BnDs achieve breadth by focusing on highly conserved residues that are accessible in two distinct V3 conformations, one of which resembles CCR5-bound V3. We further show that these V3-crown conformations can, in principle, be attacked by antibodies. Supporting this conclusion, analysis of antibody binding activity in the Swiss 4.5 K HIV-1 cohort (n = 4,281) revealed a co-evolution of V3-crown reactivities and neutralization breadth. Our results indicate a role of V3-crown responses and its conformational preferences in bnAb development to be considered in preventive and therapeutic approaches.
Keywords
Article, /631/45/612/1256, /631/45/535/1266, /631/250/2152/2153/1291, /631/326/596/1296, /692/699/255/1901, /13/1, /145, /13/31, /49/47, /38/70, article
Sponsorship
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) (314730_152663, 314730_172790, 324730B_179571, PZ00P3-142411, BSSGI0_155851, CRSK-3_190705, 310030_192689, 310030B_166676, 31003A_146278, 33CS30_148522)
EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) (681032)
Identifiers
s41467-021-27075-0, 27075
External DOI: https://doi.org/10.1038/s41467-021-27075-0
This record's URL: https://www.repository.cam.ac.uk/handle/1810/330885
Rights
Licence:
http://creativecommons.org/licenses/by/4.0/
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk